CareRx Historical Cash Flow
| CRRX Stock | CAD 1.89 0.01 0.53% |
Analysis of CareRx Corp cash flow over time is an excellent tool to project CareRx Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 2.2 M or Begin Period Cash Flow of 30.5 M as it is a great indicator of CareRx Corp ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining CareRx Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CareRx Corp is a good buy for the upcoming year.
CareRx |
About CareRx Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in CareRx balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CareRx's non-liquid assets can be easily converted into cash.
CareRx Corp Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from CareRx Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into CareRx Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CareRx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, CareRx Corp's Change To Liabilities is very stable compared to the past year. As of the 2nd of December 2024, Issuance Of Capital Stock is likely to grow to about 19.6 M, though Change In Cash is likely to grow to (20.3 M).
CareRx Corp cash flow statement Correlations
Click cells to compare fundamentals
CareRx Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CareRx Corp cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (1.3M) | 19.6M | 16.0M | (7.3M) | (21.3M) | (20.3M) | |
| Free Cash Flow | 2.9M | (1.7M) | 153K | 8.7M | 7.5M | 4.7M | |
| Change In Working Capital | (142K) | 3.7M | (3.7M) | 638K | 2.1M | 2.2M | |
| Begin Period Cash Flow | 1.4M | 61K | 19.6M | 35.6M | 29.1M | 30.5M | |
| Other Cashflows From Financing Activities | (1.8M) | 32.3M | 51.7M | (8.7M) | (5.9M) | (5.6M) | |
| Capital Expenditures | 3.5M | 2.0M | 7.1M | 13.6M | 8.7M | 4.4M | |
| Total Cash From Operating Activities | 6.4M | 229K | 7.3M | 22.3M | 16.2M | 9.1M | |
| Net Income | (29.3M) | (18.3M) | (22.7M) | (34.4M) | (5.4M) | (5.7M) | |
| Total Cash From Financing Activities | (40.1M) | 23.5M | 101.9M | (13.0M) | (25.2M) | (23.9M) | |
| End Period Cash Flow | 61K | 19.6M | 35.6M | 28.4M | 7.7M | 7.5M | |
| Depreciation | 9.3M | 11.5M | 15.4M | 20.1M | 20.0M | 13.2M | |
| Other Non Cash Items | 17.2M | 998K | 16.7M | 33.0M | 2.2M | 2.1M | |
| Stock Based Compensation | 2.3M | 2.5M | 2.7M | 4.6M | 1.5M | 2.5M | |
| Change To Account Receivables | (1.0M) | 2.5M | (11.7M) | 1.5M | 1.5M | 1.5M | |
| Change To Inventory | (525K) | 492K | (2.8M) | (2.0M) | 648K | 680.4K | |
| Sale Purchase Of Stock | 460K | 11.3M | 80.9M | 1.0M | (56K) | (53.2K) | |
| Total Cashflows From Investing Activities | 33.8M | (4.2M) | (93.2M) | (16.6M) | (14.9M) | (14.2M) | |
| Other Cashflows From Investing Activities | 38.0M | (74K) | (86.1M) | (3.0M) | (2.7M) | (2.6M) | |
| Investments | 33.8M | (4.2M) | (93.2M) | (16.6M) | (12.3M) | (11.7M) | |
| Net Borrowings | (51.8M) | 18.5M | 30.4M | (5.3M) | (6.1M) | (6.4M) | |
| Change To Operating Activities | 252K | 3.6M | (5.2M) | 307K | 276.3K | 290.1K | |
| Change To Netincome | 26.5M | 3.3M | 18.3M | 36.0M | 41.4M | 21.6M | |
| Change To Liabilities | 1.2M | (2.8M) | 15.0M | 816K | 938.4K | 985.3K |
Other Information on Investing in CareRx Stock
The Cash Flow Statement is a financial statement that shows how changes in CareRx balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CareRx's non-liquid assets can be easily converted into cash.